Invex Therapeutics Ltd (ASX:IXC)
Australia flag Australia · Delayed Price · Currency is AUD
0.130
-0.010 (-7.14%)
Apr 29, 2026, 12:28 PM AEST

Invex Therapeutics Market Cap

Invex Therapeutics has a market cap or net worth of 9.77 million as of April 29, 2026. Its market cap has increased by 116.67% in one year.

Market Cap
9.77M
Enterprise Value
5.17M
Revenue
229.08K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.13

Market Cap Chart

Since July 5, 2019, Invex Therapeutics's market cap has decreased from 59.13M to 9.77M, a decrease of -83.48%. That is a compound annual growth rate of -23.20%.

History

DateMarket Cap% Change
Apr 29, 20269.77M8.33%
Dec 30, 20259.02M81.82%
Dec 23, 20244.96M-18.52%
Dec 27, 20236.09M-85.14%
Dec 28, 202240.96M-22.70%
Dec 31, 202152.98M-1.40%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AdAlta 10.20M
Immuron 10.13M
Bio-Gene Technology 11.29M
Cambium Bio 12.30M
Chimeric Therapeutics 8.84M
Biotron 8.11M
Tissue Repair 7.86M
Vectus Biosystems 7.21M
Market Cap Rankings